The Comptroller General’s Department adds injections for hyperlipidemia starting March 1.

#Comptroller #Generals #Department #adds #injections #hyperlipidemia #starting #March

The Comptroller General’s Department adds to the list of injection medicines for patients with hyperlipidemia. Support those who have rights to access necessary and effective medicines for treatment, starting March 1 onwards.

On February 21, 2024, Mrs. Patricia Mongkhonvanit, Director-General of the Comptroller General’s Department, revealed that the Comptroller General’s Department has joined with the Thai Heart Association. under royal patronage Kidney Association of Thailand and the Endocrine Society of Thailand Set guidelines for regulating the disbursement of injection medicine costs. For patients with hyperlipidemia who use their rights to medical benefits for civil servants

By adding one more item to the list of new injectable drugs registered with the FDA after January 1, 2018, from the original 2 items patients were able to withdraw, making it now possible for patients with hypercholesterolemia to have access to medicines for treatment. There are 3 such items.

The reimbursement rate for medicines is as follows:

“So that eligible people and their families can access essential and effective medicines. Under appropriate circumstances and consistent with the budget burden Asked for cooperation from health care facilities in using such injectable drugs in accordance with the established guidelines for drug reimbursement. There is no excess cost charged to the patient,” Ms. Patricia said.

This will be effective for medical expenses incurred from 1 March 2024 onwards. If you have any questions, you can contact the Medical Welfare Division, Comptroller General’s Department, telephone number 0-2127-7000 ext. 6850 on the day and time. do